Literature DB >> 11900501

Recognition and treatment of erythema migrans: are we off target?

Robert B Nadelman, Gary P Wormser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11900501     DOI： 10.7326/0003-4819-136-6-200203190-00012

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  4 in total

Review 1.  Efficacy and Safety of Antibiotic Therapy in Early Cutaneous Lyme Borreliosis: A Network Meta-analysis.

Authors:  Gabriel Torbahn; Heidelore Hofmann; Gerta Rücker; Karin Bischoff; Michael H Freitag; Rick Dersch; Volker Fingerle; Edith Motschall; Joerg J Meerpohl; Christine Schmucker
Journal:  JAMA Dermatol       Date:  2018-11-01       Impact factor: 10.282

2.  Atypical erythema migrans in patients with PCR-positive Lyme disease.

Authors:  Steven E Schutzer; Bernard W Berger; James G Krueger; Mark W Eshoo; David J Ecker; John N Aucott
Journal:  Emerg Infect Dis       Date:  2013-05       Impact factor: 6.883

3.  Bull's-Eye and Nontarget Skin Lesions of Lyme Disease: An Internet Survey of Identification of Erythema Migrans.

Authors:  John N Aucott; Lauren A Crowder; Victoria Yedlin; Kathleen B Kortte
Journal:  Dermatol Res Pract       Date:  2012-10-24

4.  Efficacy and safety of pharmacological agents in the treatment of erythema migrans in early Lyme borreliosis-systematic review protocol.

Authors:  Gabriel Torbahn; Heidelore Hofmann; Roman Allert; Michael H Freitag; Rick Dersch; Volker Fingerle; Harriet Sommer; Edith Motschall; Jörg J Meerpohl; Christine Schmucker
Journal:  Syst Rev       Date:  2016-05-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.